My comment was pointing out that insurance if they have it wont be much good. In my (admittedly limited) experience if the legal costs are $500k you spend at least that much on internal time preparing, briefing and negotiating. It is a major distraction for management with the potential that things slip with their eyes on other things.
But the biggest potential loss is the lost opportunity to sell those products affected by the patents. This may come about in a settlement and not through a court order. These lost costs could represent hundreds of millions in the future.
Any insurance over will only cover the direct external expenses which will be much smaller than the total losses if the dispute is protracted.
- Forums
- ASX - By Stock
- RMD
- Ann: FPH FILE PATENT INFRINGEMENT PROCEEDINGS AGAINST RESMED,RMD-FPH.NZ
Ann: FPH FILE PATENT INFRINGEMENT PROCEEDINGS AGAINST RESMED,RMD-FPH.NZ, page-7
Featured News
Add RMD (ASX) to my watchlist
(20min delay)
|
|||||
Last
$36.04 |
Change
-0.620(1.69%) |
Mkt cap ! $22.01B |
Open | High | Low | Value | Volume |
$35.95 | $36.08 | $35.49 | $58.29M | 1.623M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 27 | $35.96 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$36.05 | 12289 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 27 | 35.960 |
1 | 15 | 35.950 |
1 | 576 | 35.940 |
1 | 750 | 35.900 |
1 | 19 | 35.810 |
Price($) | Vol. | No. |
---|---|---|
36.050 | 200 | 1 |
36.060 | 700 | 1 |
36.100 | 549 | 2 |
36.500 | 200 | 1 |
36.570 | 280 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
RMD (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online